HR 6423 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Help Ensure Lower Patient Copays Act
To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes.
Legislative subjects (1)
Summary
- Requires that amounts paid by or on behalf of an enrollee, including financial assistance from nonprofit organizations and prescription drug manufacturers, count toward the deductible, coinsurance, copayment, and out-of-pocket limit in group and individual health plans.
- Makes the same counting rule apply under the Affordable Care Act's essential health benefit cost-sharing provisions, applying it to prescription drugs within the prescription drug category.
- Adds a safe harbor so that a high deductible health plan with a health savings account does not lose its status when manufacturer or nonprofit assistance for outpatient prescription drugs counts toward the minimum deductible, for plan years beginning after December 31, 2025.
- Limits the counting rule to specialty drugs and to drugs subject to utilization management, and states that it does not affect prior authorization or step therapy.
- Applies these requirements to group health plans and health insurers for plan years beginning on or after January 1, 2026.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
Rep. Kean, Thomas H. (R-NJ) [#7]
62 cosponsors
-
Del. Norton, Eleanor Holmes (D-DC) [At-large] -
Rep. Adams, Alma S. (D-NC) [#12] -
Rep. Auchincloss, Jake (D-MA) [#4] -
Rep. Balint, Becca (D-VT) [At-large] -
Rep. Barragán, Nanette Diaz (D-CA) [#44] -
Rep. Barrett, Tom (R-MI) [#7] -
Rep. Bonamici, Suzanne (D-OR) [#1] -
Rep. Bynum, Janelle S. (D-OR) [#5] -
Rep. Case, Ed (D-HI) [#1] -
Rep. Ciscomani, Juan (R-AZ) [#6] -
Rep. Cohen, Steve (D-TN) [#9] -
Rep. Conaway, Herbert C. (D-NJ) [#3] -
Rep. Crow, Jason (D-CO) [#6] -
Rep. Davids, Sharice (D-KS) [#3] -
Rep. Dean, Madeleine (D-PA) [#4] -
Rep. DelBene, Suzan K. (D-WA) [#1] -
Rep. DeSaulnier, Mark (D-CA) [#10] -
Rep. Fine, Randy (R-FL) [#6] -
Rep. Fitzpatrick, Brian K. (R-PA) [#1] -
Rep. Foster, Bill (D-IL) [#11] -
Rep. Foushee, Valerie P. (D-NC) [#4] -
Rep. Garamendi, John (D-CA) [#8] -
Rep. García, Jesús G. "Chuy" (D-IL) [#4] -
Rep. Goldman, Daniel S. (D-NY) [#10] -
Rep. Gottheimer, Josh (D-NJ) [#5] -
Rep. Hayes, Jahana (D-CT) [#5] -
Rep. Houlahan, Chrissy (D-PA) [#6] -
Rep. Kennedy, Timothy M. (D-NY) [#26] -
Rep. Kiggans, Jennifer A. (R-VA) [#2] -
Rep. LaLota, Nick (R-NY) [#1] -
Rep. Lee, Summer L. (D-PA) [#12] -
Rep. Levin, Mike (D-CA) [#49] -
Rep. Lieu, Ted (D-CA) [#36] -
Rep. Lynch, Stephen F. (D-MA) [#8] -
Rep. Matsui, Doris O. (D-CA) [#7] -
Rep. McCollum, Betty (D-MN) [#4] -
Rep. Meuser, Daniel (R-PA) [#9] -
Rep. Miller-Meeks, Mariannette (R-IA) [#1] -
Rep. Mills, Cory (R-FL) [#7] -
Rep. Moulton, Seth (D-MA) [#6] -
Rep. Panetta, Jimmy (D-CA) [#19] -
Rep. Pappas, Chris (D-NH) [#1] -
Rep. Pfluger, August (R-TX) [#11] -
Rep. Pingree, Chellie (D-ME) [#1] -
Rep. Pocan, Mark (D-WI) [#2] -
Rep. Quigley, Mike (D-IL) [#5] -
Rep. Riley, Josh (D-NY) [#19] -
Rep. Ross, Deborah K. (D-NC) [#2] -
Rep. Rutherford, John H. (R-FL) [#5] -
Rep. Salazar, Maria Elvira (R-FL) [#27] -
Rep. Schrier, Kim (D-WA) [#8] -
Rep. Simon, Lateefah (D-CA) [#12] -
Rep. Sorensen, Eric (D-IL) [#17] -
Rep. Stevens, Haley M. (D-MI) [#11] -
Rep. Subramanyam, Suhas (D-VA) [#10] -
Rep. Suozzi, Thomas R. (D-NY) [#3] -
Rep. Thanedar, Shri (D-MI) [#13] -
Rep. Tokuda, Jill N. (D-HI) [#2] -
Rep. Torres, Ritchie (D-NY) [#15] -
Rep. Vasquez, Gabe (D-NM) [#2] -
Rep. Watson Coleman, Bonnie (D-NJ) [#12] -
Rep. Wilson, Joe (R-SC) [#2]
Actions (2)
- Dec 4, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- Dec 4, 2025 Introduced in House
Full text
IN THE HOUSE OF REPRESENTATIVES
December 4, 2025
Mr. Kean (for himself, Ms. Barragan, Mrs. Miller-Meeks, Mr. Auchincloss, Mr. Fitzpatrick, and Mrs. Watson Coleman) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Help Ensure Lower Patient Copays Act” or the “HELP Copays Act”.
SEC. 2. APPLICATION OF FINANCIAL ASSISTANCE TOWARD COST-SHARING REQUIREMENTS.
(a) Application Toward Cost-Sharing Requirements.—Section 2715(g)(1) of the Public Health Service Act (42 U.S.C. 300gg-15(g)(1)) is amended by adding at the end the following: “In developing the standards for defining the terms ‘deductible’, ‘coinsurance’, ‘copayment’, and ‘out-of-pocket limit’ (as described in paragraph (2)), such standards shall provide that such terms include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and that such amounts shall be counted toward such deductible, coinsurance, copayment, or limit, respectively.”.
(b) Conforming Amendments.—
(1) PPACA.—Section 1302(c)(3) of the Patient Protection and Affordable Care Act (42 U.S.C. 18022(c)(3)) is amended by adding at the end the following new subparagraph:
“(C) Application of terms.—For purposes of subparagraph (A), the terms ‘deductible’, ‘coinsurance’, ‘copayment’, or ‘similar charge’ and any other expenditure described in clause (ii) of such subparagraph shall include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and such amounts shall be counted toward such deductible, co-insurance, co-payment, charge, or other expenditure, respectively.”.
(2) PHSA.—Section 2707(b) of the Public Health Service Act (42 U.S.C. 300gg-6(b)) is amended by adding at the end the following new sentence: “For purposes of the previous sentence, such limitation shall be applied to prescription drugs as if the reference to ‘essential health benefits’ in section 1302(c)(3) of the Patient Protection and Affordable Care Act were a reference to ‘any item or service covered under the plan included within the prescription drug category of essential health benefits as described in (b)(1)(F) of such section’.”.
(3) Internal revenue code of 1986 safe harbor for certain amounts applied to deductibles.—Section 223(c)(2) of the Internal Revenue Code of 1986 is amended by adding at the end the following new subparagraph:
“(H) Safe harbor for certain amounts applied to deductibles.—In the case of plan years beginning after December 31, 2025, a plan shall not fail to be treated as a high deductible health plan by reason of counting amounts paid by, or on behalf of, an individual, including financial assistance offered by non-profit organizations and prescription drug manufacturers for outpatient prescription drugs, when determining whether the minimum deductible under subparagraph (A) has been satisfied.”.
(c) Rule of Construction.—The amendments made by this section shall—
(1) apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to prescription drugs that are specialty drugs;
(2) apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to drugs that are subject to utilization management; and
(3) not impact the use of utilization management tools, including prior authorization and step therapy.
(d) Effective Date.—This section, and the amendments made by this section, shall apply to group health plans and health insurance issuers for plan years beginning on or after January 1, 2026. <all>
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Comments